Mission

IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions.

Join IDEOM

To become a stakeholder with IDEOM, participation in Delphi surveys, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE

Interested in creating a workgroup?
SUBMIT YOUR APPLICATION HERE

A Note From Our President:

"The true finish line is when the patient gets to the right doctor and the right treatment and their disease has minimal to no impact on their quality of life."

-Alice Gottlieb, MD, PhD

Welcome to the International Dermatology Outcome Measures

International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.

To become a stakeholder with IDEOM, participation in Delphi survey's, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE

   


CALL FOR IDEOM FELLOWSHIP

The International Dermatology Outcome Measures (IDEOM) is now accepting fellowship applications for the 2022 year. The fellowship is for a one to two year term. The fellow is expected to be actively involved in clinical research and educational activities across multiple IDEOM workgroups. The fellow is expected to have good medical writing skills and will participate in writing protocol and consent forms and in writing papers. Additionally, the fellow will be active in supporting the activities of IDEOM annual meetings.

Through this fellowship, IDEOM can engage fellows in carrying out the mission to validate measures throughout dermatology. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions.

The body of evidence on outcomes measures for dermatological diseases varies widely and lacks agreement on standardized measures. This absence of evidence-based, consensus-driven, and widely accepted outcomes measures may impede patients from receiving access to the most effective and appropriate treatments available. Without such outcomes measures, researchers and health care providers lack critical benchmarks for making treatment recommendations and evaluating patient progress, and payers lack the information needed to determine the efficacy of various treatments, information that is key to shaping payment policies. Given the higher prices associated with many dermatology treatments and a misperception that many conditions are “cosmetic,” the absence of clear outcomes measures could result in payers providing minimal to no coverage for various therapies, curtailing patient access to care.

Fellows appointed to this position will work with IDEOM stakeholders.

QUALIFICATIONS

Position open to:

  • 3rd to 5th year medical student or
  • MD or MD/PhD degree and completion of at least 1 year PGY1 residency(by June 30) or
  • Fellows may also have already completed a dermatology, medicine or pediatrics residency or rheumatology fellowship

Please submit an updated CV and 3 references to amanda@dermoutcomes.org



A Prayer for IDEOM

Adapted from the Mishkan T'Filah,: A Reform Siddur. Central Conference of American Rabbis, New York, 2007.


UPCOMING EVENTS

2022 IDEOM
Annual Meeting

June 17 - 18, 2022
Details Coming Soon...

IDEOM POLICY:

To remain eligible for travel reimbursement for all future in-person meetings, all stakeholders MUST attend the two (2) days of the virtual annual meeting in its entirety.


CALL FOR ABSTRACTS

The IDEOM Board of Directors will select abstracts for poster presentation at the 2022 Annual Meeting. Posters will be available for viewing at the Annual Meeting during designated breaks. There will not be an opportunity to present at the podium during working meetings.

DEADLINE: Friday, April 15, 2022


IN THE NEWS

IDEOM President ALICE GOTTLIEB,MD,PHD RECEIVES OUTSTANDING SCIENTIFIC ACHIEVEMENT AWARD BY THE NATIONAL PSORIASIS FOUNDATION

National Psoriasis Foundation has chosen IDEOM Founder and President Dr. Alice Gottlieb to receive the Outstanding Scientific Achievement award for 2021.

Through the NPF Researcher Awards program, NPF honors scientists who have made a unique impact on psoriatic disease research.

The Outstanding Scientific Achievement award recognizes outstanding scientific achievement in psoriatic disease research, taking into consideration independence of thought, originality, significance of discovery, and impact on his/her area of research.


Why Join IDEOM?

Join a community of like-minded researchers and stakeholders as we work for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Learn the facts...